DJIA 17,090.28 -23.26 -0.14%
NASDAQ 4,473.73 17.71 0.40%
S&P 500 1,987.87 4.34 0.22%
market minute promo

258.82 5.14 (2.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IBB $258.82 2.03%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $257.77
Previous Close $253.68
Daily Range $257.02 - $260.31
52-Week Range $187.05 - $275.40
Market Cap $5.2B
P/E Ratio -1,102.96
Dividend (Yield) $1.57 (0.2%)
Ex-Dividend Date
Dividend Pay Date
06/25/14
07/01/14
Volume 1,326,170
Average Daily Volume 1,286,401
Current FY EPS $0.00

Sector

Financials

Industry

Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website: http://www.ishares.com/

News & Commentary

Is This the Most Undervalued Biotech of 2013?

Biotechs roared in 2013. Questcor was no exception, but it still just might be the most undervalued biotech of the year.

Today's Market: Biotech Names Rallying Today

S&P 500 Revenue Trends Are Improving in Q2

Companies are reporting very solid revenues this earnings season.

The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary

Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market

Fed: These Two Industries Look Overvalued - Real Time Insight

Stop that crazy Yellen!

Why This Institutional Favorite Tops My List of Stocks

Todd Harrison: Thoughts on Janet Yellen's Congressional Testimony

How can social media valuations be considered "high" when the sector is new?

Yellen Says Social Media, Biotech Stocks 'Substantially Stretched'

Yellen Sees Social Media, Biotech, Junk Bonds and Leveraged Loans Overvalued

See More IBB News...

IBB's Top Competitors

IBB $258.82 (2.03%)
Current stock: IBB
VTA $12.96 (0.10%)
Current stock: VTA
NCV $10.44 (0.29%)
Current stock: NCV
ZTR $14.45 (0.00%)
Current stock: ZTR